The biotech M&A bonanza shows no sign of slowing down and is boosting trusts able to identify assets that are attractive to acquirers. One such fund is the International Biotechnology Trust (LON:IBT), which has now seen nine portfolio companies acquired in 2026-to-date. That matches the total number of IBT portfolio takeovers seen in the whole … Continue reading International Biotechnology Trust boosted by ninth takeover of 2026